UBS upgrades Pfizer (PFE +1.2%) to Buy, saying the selloff since agreeing to buy Wyeth (WYE...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

UBS upgrades Pfizer (PFE +1.2%) to Buy, saying the selloff since agreeing to buy Wyeth (WYE +0.8%) is overdone, making shares "very attractive." Also upgrades WYE to Buy, seeing "very little risk" of deal falling through.